NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,114,000 | 0.0% | 900,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,114,000 | +47.5% | 900,000 | +50.0% | 0.00% | – |
Q3 2021 | $755,000 | -5.3% | 600,000 | 0.0% | 0.00% | – |
Q2 2021 | $797,000 | -1.2% | 600,000 | 0.0% | 0.00% | – |
Q1 2021 | $807,000 | +94.9% | 600,000 | +100.0% | 0.00% | – |
Q4 2020 | $414,000 | +0.2% | 300,000 | 0.0% | 0.00% | – |
Q3 2020 | $413,000 | -63.0% | 300,000 | -55.4% | 0.00% | -100.0% |
Q2 2020 | $1,117,000 | +86.8% | 672,000 | +43.9% | 0.00% | 0.0% |
Q1 2020 | $598,000 | -16.4% | 467,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $715,000 | -55.6% | 467,000 | -60.3% | 0.00% | 0.0% |
Q3 2019 | $1,609,000 | -26.8% | 1,175,000 | -29.9% | 0.00% | -50.0% |
Q2 2019 | $2,198,000 | +14.5% | 1,675,000 | +18.0% | 0.00% | 0.0% |
Q1 2019 | $1,919,000 | +436.0% | 1,420,000 | +373.3% | 0.00% | – |
Q4 2018 | $358,000 | -73.7% | 300,000 | -62.5% | 0.00% | -100.0% |
Q3 2018 | $1,363,000 | -46.0% | 800,000 | -54.3% | 0.00% | -50.0% |
Q2 2018 | $2,526,000 | – | 1,750,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |